Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Davis

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 14, 2015
Noise robustness of unpredictability in a chaotic laser system: toward reliable physical random bit generationMasanobu Inubushi, Kazuyuki Yoshimura, Peter Davis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price NeutralityCharon Lessing, Toni Ashton, Peter Davis
Administration and Policy in Mental Health|October 22, 2014
Do users of risperidone who switch brands because of generic reference pricing fare better or worse than non-switchers? A New Zealand natural experimentCharon Lessing, Toni Ashton, Peter Davis
Archives of Disease in Childhood. Fetal and Neonatal Edition|August 3, 2014
Efficacy and safety of bubble CPAP in neonatal care in low and middle income countries: a systematic reviewSimone Martin, Trevor Duke, Peter Davis
Applied Health Economics and Health Policy|July 10, 2014
The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: the case of lamotrigine in New ZealandCharon Lessing, Toni Ashton, Peter Davis
Archives of Disease in Childhood|July 21, 2012
Tracheostomy in children admitted to paediatric intensive careDora Wood, Philip McShane, Peter Davis
Australian Health Review : a Publication of the Australian Hospital Association|September 14, 2015
New Zealand patients' understanding of brand substitution and opinions on copayment options for choice of medicine brandCharon Lessing, Toni Ashton, Peter Davis
Pediatrics|November 5, 2002
Effect of AAP statement regarding postnatal corticosteroids on ongoing and future randomized, controlled trialsLex Doyle, Peter Davis, Colin Morley, et al.
Physical Review. E|November 20, 2020
Rate distortion theorem and the multicritical point of a spin glassTatsuto Murayama, Asaki Saito, Peter Davis
The New Zealand Medical Journal|May 22, 2007
Doctors, practices, patients, and their problems during usual hours: a description of rural and non-rural primary care in New Zealand in 2001-2002Phil Hider, Roy Lay-Yee, Peter Davis
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 14, 2015
Noise robustness of unpredictability in a chaotic laser system: toward reliable physical random bit generationMasanobu Inubushi, Kazuyuki Yoshimura, Peter Davis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price NeutralityCharon Lessing, Toni Ashton, Peter Davis
Administration and Policy in Mental Health|October 22, 2014
Do users of risperidone who switch brands because of generic reference pricing fare better or worse than non-switchers? A New Zealand natural experimentCharon Lessing, Toni Ashton, Peter Davis
Archives of Disease in Childhood. Fetal and Neonatal Edition|August 3, 2014
Efficacy and safety of bubble CPAP in neonatal care in low and middle income countries: a systematic reviewSimone Martin, Trevor Duke, Peter Davis
Applied Health Economics and Health Policy|July 10, 2014
The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: the case of lamotrigine in New ZealandCharon Lessing, Toni Ashton, Peter Davis
Archives of Disease in Childhood|July 21, 2012
Tracheostomy in children admitted to paediatric intensive careDora Wood, Philip McShane, Peter Davis
Australian Health Review : a Publication of the Australian Hospital Association|September 14, 2015
New Zealand patients' understanding of brand substitution and opinions on copayment options for choice of medicine brandCharon Lessing, Toni Ashton, Peter Davis
Pediatrics|November 5, 2002
Effect of AAP statement regarding postnatal corticosteroids on ongoing and future randomized, controlled trialsLex Doyle, Peter Davis, Colin Morley, et al.
Physical Review. E|November 20, 2020
Rate distortion theorem and the multicritical point of a spin glassTatsuto Murayama, Asaki Saito, Peter Davis
The New Zealand Medical Journal|May 22, 2007
Doctors, practices, patients, and their problems during usual hours: a description of rural and non-rural primary care in New Zealand in 2001-2002Phil Hider, Roy Lay-Yee, Peter Davis
Pageof 23